Casa Verde Capital — 2021 Investments
6 investments dated 2021 · listed companies and verified rows first · show all
AceCann cultivates, processes, and extracts medical cannabis products aimed at the European market.
BiotechHealthtechVendas Novas, PT
Ivanshu Shantilal(CEO)Frederico Brito e Abreu(Co-Founder and Investor | Board Member)Pedro Trinité(Co-Founder and Investor | Board Member)Tiago Bartolomeu(Co-Founder and Investor | Board Member)Pedro Gomes(CEO)
Co-investorsAmaral Family InvestmentsBlueCrow CapitalLince Capital
Delix Therapeutics develops third-generation, non-hallucinogenic neuroplastogens for people with neurological conditions, using a discovery platform to identify novel compounds.
BiotechDigital HealthMedical Devices
David Olson(Founder)David Olson Nick Haft(Founder)Nick Haft(Founder)
Co-investorsArtis VenturesBailey Venture PartnersDolby Family VenturesGaingelsIaso VenturesNoetic+9 more
Pistil provides data analytics and strategy services for cannabis industry businesses, turning market and operational data into decisions that support growth.
AI & Machine LearningData & InfrastructureRetail TechSaaSMill Valley, US
Jeffrey Graham(CEO)inTaylor Jones(CRO)inYonatan Moshe Meyer(Director)
SentiLink provides fraud detection and identity verification products and data solutions for financial institutions and businesses.
AI & Machine LearningCybersecurityData & InfrastructureFintechSan Francisco, US
Max(Co-founder)Maxwell Blumenfeld(Founder)inNaftali Harris(Founder)inMax Blumenfeld(Founder)
Co-investorsAndreessen HorowitzCraft VenturesFelicis VenturesFifth Down CapitalFlexcap VenturesNew York Life Ventures+30 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.





__Twitter.png)









